Dr. Reddy’s Is BofA’s Top Pick In Indian Pharma On Earnings Visibility

BofA has chosen Dr. Reddy’s Laboratories Ltd. as its top pick in the Indian pharma space, as its sees earnings visibility in the near term. Two years of outperformance-boosted valuation and gross margin tailwinds point to positive earnings momentum, BoFA said.

The brokerage has a ‘buy’ rating on…